AKR1B1 and type 2 diabetes mellitus: Aldose Reductase (AKR1B1) and Protein Tyrosine Phosphatase 1B (PTP1B) represent two insulin-resistance-related targets involved in the development of type 2 diabetes mellitus (T2DM) and its chronic complications.